Category | Variables | Baseline | 6 months | 12 months |
Demographics | Age | x | x | x |
Gender | x | |||
Highest education | x | |||
Social status | x | |||
Height | x | |||
Weight | x | x | x | |
BMI | x | x | x | |
Smoking status | x | x | x | |
Smoking duration | x | x | x | |
Smoking pack years | x | x | x | |
Menopausal status | x | |||
Postmenopausal hormone use | x | |||
Race | x | |||
Cancer characteristics | Cancer site | x | ||
Cancer stage | x | |||
TNM classification | x | |||
Treatment | Preoperative chemotherapy | x | ||
Preoperative radiotherapy | x | |||
Surgery | x | x | ||
Postoperative chemotherapy | x | x | ||
Postoperative radiotherapy | x | x | ||
Supplement intake | Folic acid supplements | x | x | x |
Vitamin B2 supplements | x | x | x | |
Vitamin B6 supplements | x | x | x | |
Vitamin B12 supplements | x | x | x | |
Vitamin A supplements | x | x | x | |
Vitamin C supplements | x | x | x | |
Vitamin D supplements | x | x | x | |
(Supplement intake | Vitamin E supplements | x | x | x |
Calcium supplements | x | x | x | |
Magnesium supplements | x | x | x | |
Iron supplements | x | x | x | |
Multivitamins | x | x | x | |
Dietary nutrients | Folate equivalents | x | x | x |
Vitamin B2 | x | x | x | |
Vitamin B6 | x | x | x | |
Vitamin B12 | x | x | x | |
Vitamin A | x | x | x | |
Vitamin C | x | x | x | |
Vitamin D | x | x | x | |
Vitamin E | x | x | x | |
Total protein | x | x | x | |
Total fat | x | x | x | |
Total carbohydrate | x | x | x | |
Dietary nutrients | Fibre | x | x | x |
Saturated fatty acids | x | x | x | |
Monounsaturated fatty acids | x | x | x | |
Polyunsaturated fatty acids | x | x | x | |
Alcohol | x | x | x | |
Total energy | x | x | x | |
Physical activity | Light physical activity | x | x | x |
Moderate physical activity | x | x | x | |
Vigorous physical activity | x | x | x | |
Adherence to physical activity guidelines | x | x | x | |
Medical history | Diabetes mellitus | x | x | x |
Asthma, chronical bronchitis, COPD, emphysema | x | |||
Heart attack, heart failure | x | |||
Hypertension | x | |||
Stroke | x | |||
Ulcer of stomach or duodenum | x | |||
Hypothyroidism/hyperthyroidism | x | |||
Systemic lupus erythematosus | x | |||
Inflammatory bowel disease (Crohn’s disease, ulcerative colitis) | x | |||
Familial adenomatous polyposis | x | |||
Medical history | Lynch syndrome (hereditary nonpolyposis colorectal cancer) | x | ||
Regular medication use | Aspirin | x | x | x |
NSAID | x | x | x | |
Ibuprofen | x | x | x | |
Naproxen | x | x | x | |
Celecoxib/etoricoxib | x | x | x | |
Health-related quality of life | EORTC QLQ-C30 | x | x | x |
EORTC QLQ-CR29 | x | x | x | |
EORTC QLQ-CIPN20 | x | x | x | |
General information | Date of questionnaire completion | x | x | x |
Date of blood collection | x | x | x | |
Freeze-thaw cycles of blood samples | x | x | x | |
Haemolysis | x | x | x | |
Time between blood draw and processing/storage | x | x | x |
BMI, body mass index; C30, core 30-items; CIPN20, chemotherapy-induced polyneuropathy 20-items.; COPD, Chronic Obstructive Pulmonary Disease; CR29, colon/rectum 29-items; EORTC, European Organisation for Research and Treatment of Cancer; NSAID, non-steroidal anti-inflammatory drug; QLQ, quality of life questionnaire; TNM, tumor, nodes, and metastases.